Learn More
Apexbio Technology LLC ML-7 hydrochloride 110448-33-4 10mM (in 1mL DMSO)

Supplier: Apexbio Technology LLC A36265.1
ML-7 hydrochloride (CAS 110448-33-4) is a potent inhibitor of myosin light chain kinase (MLCK) with a reported Ki of 300 nM By inhibiting MLCK ML-7 modulates the phosphorylation state of myosin light chains a process implicated in the pathogenesis of cardiovascular disorders and ischemia/reperfusion (I/R) injury In vitro ML-7 suppresses neuregulin-1-induced sarcomere formation in cultured neonatal rat cardiomyocytes In vivo administration of ML-7 during I/R protocols in rat models significantly improves cardiac contractility and alters the expression of proteins involved in energy metabolism and cytoskeletal organization ML-7 is widely utilized as a research tool to dissect MLCK-dependent signaling pathways in cardiovascular and cellular physiology
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.